サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1423838

宿主細胞汚染物質検査の世界市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2031年）- 製品タイプ別、プラットフォーム別、用途別、エンドユーザー別、地域別

Host Cell Contaminant Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region:

出版日
ページ情報
英文 198 Pages
納期
2～5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.35円
宿主細胞汚染物質検査の世界市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2031年）- 製品タイプ別、プラットフォーム別、用途別、エンドユーザー別、地域別
出版日: 2024年01月29日
発行: Fairfield Market Research
ページ情報: 英文 198 Pages
納期: 2～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

バイオ医薬品のダイナミックな状況において、宿主細胞の汚染物質の同定と定量は、新規治療薬の安全性と有効性を確保する上で極めて重要な課題です。酵母、大腸菌、哺乳類細胞など様々な由来の宿主細胞タンパク質は、様々な性質、等電点、分子量を持つ異種混合物です。バイオ医薬品産業が革新を続ける中、強固な宿主細胞汚染物質検査ソリューションへの需要が高まっています。

宿主細胞汚染物質検査分野の多様な利害関係者の中で、バイオ製薬企業がフロントランナーとして台頭し、その大きな市場シェアと医薬品開発・製造の広範な専門知識で市場開拓を牽引しています。最近の市場分析によると、バイオ製薬企業は世界の宿主細胞汚染物質検査市場で大きなシェアを占めており、この傾向は予測期間中も続くと予測されています。

確立された生産能力、経済力、戦略的市場インフラを持つバイオ製薬大手は、新薬の開発から市場開拓に極めて重要な役割を果たしています。さらに、これらの企業は、新興のバイオ医薬品企業と提携や共同研究を行うことが多く、そのリソースを活用して研究資金を調達し、顧客基盤を拡大し、医薬品開発と商業化の複雑な情勢を乗り切っています。

バイオ医薬品企業は、製品の品質と規制遵守を確保する上で宿主細胞の汚染物質検査が極めて重要であることを認識し、先進的な検査手法への投資を増やしています。これらの企業は、抗体や低分子医薬品などリスクの低い後期段階の製品を優先することで、医薬品開発と商業化のペースを加速させながらリスクを軽減することを目指しています。

バイオ製薬企業の台頭とともに、受託研究機関（CRO）は宿主細胞汚染物質検査市場において強力な競争相手として台頭する構えを見せています。大手製薬企業との戦略的提携や契約を通じて、CROは前臨床および臨床研究の専門知識を活用し、包括的な検査サービスを提供しています。

既存の投資家の出資比率を希薄化させる従来の投資モデルとは異なり、CROは代替的な資金調達手段を模索し、自らを医薬品開発のエコシステムにおける不可欠なパートナーとして位置づけています。前臨床評価、毒性試験、臨床試験を実施することで、CROは医薬品開発プロセスを迅速化すると同時に、規制遵守と患者の安全性を確保する上で重要な役割を果たしています。

同様に、製造受託機関（CMO）はバイオ医薬品のバリューチェーンに欠かせない存在であり、特定の医薬品要件に合わせた専門的な製造能力を提供しています。CROやバイオ製薬企業と密接に協力することで、CMOは医薬品開発から商業生産へのシームレスな移行を促進し、製品ライフサイクル全体を通じて拡張性と効率性を確保しています。

今後、世界の宿主細胞汚染物質検査市場は、新規治療薬の絶え間ない追求と、品質保証と規制遵守の重視の高まりにより、大きく拡大する見通しです。バイオ製薬企業が技術革新を推進し、戦略的パートナーシップを構築し続けているため、高度な検査ソリューションに対する需要が急増すると予想されます。

当レポートでは、世界の宿主細胞汚染物質検査市場について調査し、市場の概要とともに、製品タイプ別、プラットフォーム別、用途別、エンドユーザー別、地域別動向、および市場に参入する企業の競合動向などを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場の定義とセグメンテーション
  • 市場力学
  • バリューチェーン分析
  • ポーターのファイブフォース分析
  • COVID-19の影響分析
  • ウクライナとロシアの紛争の影響
  • 経済概要
  • PESTLE分析

第3章 世界の宿主細胞汚染物質検査市場の見通し、2018年～2031年

  • 世界の宿主細胞汚染物質検査市場の見通し、製品タイプ別、金額（10億米ドル）、2018年～2031年
  • 世界の宿主細胞汚染物質検査市場の見通し、プラットフォーム別、金額（10億米ドル）、2018年～2031年
  • 世界の宿主細胞汚染物質検査市場の見通し、用途別、金額（10億米ドル）、2018年～2031年
  • 世界の宿主細胞汚染物質検査市場の見通し、エンドユーザー別、金額（10億米ドル）、2018年～2031年
  • 世界の宿主細胞汚染物質検査市場の見通し、地域別、金額（10億米ドル）、2018年～2031年

第4章 北米の宿主細胞汚染物質検査市場の見通し、2018年～2031年

第5章 欧州の宿主細胞汚染物質検査市場の見通し、2018年～2031年

第6章 アジア太平洋の宿主細胞汚染物質検査市場の見通し、2018年～2031年

第7章 ラテンアメリカの宿主細胞汚染物質検査市場の見通し、2018年～2031年

第8章 中東・アフリカの宿主細胞汚染物質検査市場の見通し、2018年～2031年

第9章 競合情勢

  • 製品タイプとプラットフォームのヒートマップ
  • メーカーとプラットフォームのヒートマップ
  • 企業の市場シェア分析、2023年
  • 競争力ダッシュボード
  • 企業プロファイル
    • BioGenes GmbH
    • Bio-Rad Laboratories, Inc.
    • Cisbio Bioassays
    • Cygnus Technologies LLC
    • Enzo Life Sciences, Inc.
    • ForteBio
    • GE Healthcare Life Sciences
    • Molecular Devices LLC
    • ProteinSimple
    • Thermo Fisher Scientific, Inc.

第10章 付録

目次

In the dynamic landscape of biopharmaceuticals, the identification and quantification of host cell contaminants stand as pivotal tasks in ensuring the safety and efficacy of novel therapeutics. Host cell proteins, originating from diverse sources such as yeast, E. coli, and mammalian cells, present a heterogeneous mix with varying properties, isoelectric points, and molecular masses. As the biopharmaceutical industry continues to innovate, the demand for robust host cell contaminant testing solutions is on the rise.

Bio-Pharmaceutical Companies Spearhead Market Growth

Among the diverse stakeholders in the host cell contaminant testing arena, bio-pharmaceutical companies emerge as frontrunners, driving market expansion with their substantial market share and extensive expertise in drug development and manufacturing. Recent market analysis indicates that bio-pharmaceutical companies commanded a significant share in the global host cell contaminant testing market, a trend projected to persist in the forecast period.

With their established production capabilities, economic prowess, and strategic market infrastructure, bio-pharmaceutical giants play a pivotal role in shepherding novel drugs from development to market introduction. Moreover, these companies often engage in partnerships and collaborations with emerging biopharmaceutical entities, leveraging their resources to finance research, expand customer bases, and navigate the complex landscape of drug development and commercialization.

Recognizing the critical importance of host cell contaminant testing in ensuring product quality and regulatory compliance, bio-pharmaceutical companies are increasingly investing in advanced testing methodologies. By prioritizing low-risk, late-stage products such as antibodies and small molecule drugs, these companies aim to mitigate risks while accelerating the pace of drug development and commercialization.

Rising Role of Contract Research Organizations (CROs)

In tandem with the ascendancy of bio-pharmaceutical companies, contract research organizations (CROs) are poised to emerge as formidable contenders in the host cell contaminant testing market. Through strategic partnerships and agreements with leading pharmaceutical entities, CROs are leveraging their expertise in preclinical and clinical research to offer comprehensive testing services.

Unlike traditional investment models that dilute existing investor stakes, CROs are exploring alternative financing avenues, positioning themselves as indispensable partners in the drug development ecosystem. By conducting preclinical evaluations, toxicology studies, and clinical trials, CROs play a vital role in expediting the drug development process while ensuring regulatory compliance and patient safety.

Similarly, contract manufacturing organizations (CMOs) are integral players in the biopharmaceutical value chain, offering specialized manufacturing capabilities tailored to specific drug requirements. By collaborating closely with CROs and bio-pharmaceutical companies, CMOs facilitate seamless transitions from drug development to commercial production, ensuring scalability and efficiency throughout the product lifecycle.

Market Outlook and Future Prospects

Looking ahead, the global host cell contaminant testing market is poised for significant expansion, driven by the relentless pursuit of novel therapeutics and the increasing emphasis on quality assurance and regulatory compliance. As bio-pharmaceutical companies continue to drive innovation and forge strategic partnerships, the demand for advanced testing solutions is expected to surge.

Moreover, the growing role of CROs and CMOs in the biopharmaceutical ecosystem underscores the importance of collaborative approaches in drug development and manufacturing. By harnessing collective expertise and resources, stakeholders across the industry are poised to accelerate the pace of innovation and bring life-saving treatments to patients worldwide.

Competitive Analysis

Key companies functioning in the global host cell contaminant testing market including:

  • BioGenes GmbH
  • Bio-Rad Laboratories, Inc.
  • Cisbio Bioassays
  • Cygnus Technologies LLC (A Maravai Lifesciences Company)
  • Enzo Life Sciences, Inc.
  • ForteBio (A Pall Company)
  • GE Healthcare Life Sciences
  • Molecular Devices LLC
  • ProteinSimple (A BioTechne Brand)
  • Thermo Fisher Scientific, Inc.
  • Others

Market Segmentation

Product Type

  • PCR-based Assays
  • ELISA-based Assays

Platform

  • Microbial
  • Mammalian
  • Others

Application

  • Research & Development
  • Clinical Applications

End User

  • Biopharmaceutical Companies
  • Contract Research Organizations
  • Contract Manufacturing Organizations
  • Academic & Research Institutes

Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Host Cell Contaminant Testing Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Global Host Cell Contaminant Testing Market Outlook, 2018 - 2031

  • 3.1. Global Host Cell Contaminant Testing Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
    • 3.1.1. Key Highlights
      • 3.1.1.1. PCR-based Assays
      • 3.1.1.2. ELISA-based Assays
  • 3.2. Global Host Cell Contaminant Testing Market Outlook, by Platform, Value (US$ Bn), 2018 - 2031
    • 3.2.1. Key Highlights
      • 3.2.1.1. Microbial
      • 3.2.1.2. Mammalian
      • 3.2.1.3. Others
  • 3.3. Global Host Cell Contaminant Testing Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
    • 3.3.1. Key Highlights
      • 3.3.1.1. Research & Development
      • 3.3.1.2. Clinical Applications
  • 3.4. Global Host Cell Contaminant Testing Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 3.4.1. Key Highlights
      • 3.4.1.1. Biopharmaceutical Companies
      • 3.4.1.2. Contract Research Organizations
      • 3.4.1.3. Contract Manufacturing Organizations
      • 3.4.1.4. Academic & Research Institutes
  • 3.5. Global Host Cell Contaminant Testing Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
    • 3.5.1. Key Highlights
      • 3.5.1.1. North America
      • 3.5.1.2. Europe
      • 3.5.1.3. Asia Pacific
      • 3.5.1.4. Latin America
      • 3.5.1.5. Middle East & Africa

4. North America Host Cell Contaminant Testing Market Outlook, 2018 - 2031

  • 4.1. North America Host Cell Contaminant Testing Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
    • 4.1.1. Key Highlights
      • 4.1.1.1. PCR-based Assays
      • 4.1.1.2. ELISA-based Assays
  • 4.2. North America Host Cell Contaminant Testing Market Outlook, by Platform, Value (US$ Bn), 2018 - 2031
    • 4.2.1. Key Highlights
      • 4.2.1.1. Microbial
      • 4.2.1.2. Mammalian
      • 4.2.1.3. Others
  • 4.3. North America Host Cell Contaminant Testing Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
    • 4.3.1. Key Highlights
      • 4.3.1.1. Research & Development
      • 4.3.1.2. Clinical Applications
  • 4.4. North America Host Cell Contaminant Testing Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 4.4.1. Key Highlights
      • 4.4.1.1. Biopharmaceutical Companies
      • 4.4.1.2. Contract Research Organizations
      • 4.4.1.3. Contract Manufacturing Organizations
      • 4.4.1.4. Academic & Research Institutes
  • 4.5. North America Host Cell Contaminant Testing Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 4.5.1. Key Highlights
      • 4.5.1.1. U.S. Host Cell Contaminant Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 4.5.1.2. U.S. Host Cell Contaminant Testing Market by Platform, Value (US$ Bn), 2018 - 2031
      • 4.5.1.3. U.S. Host Cell Contaminant Testing Market by Application, Value (US$ Bn), 2018 - 2031
      • 4.5.1.4. U.S. Host Cell Contaminant Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 4.5.1.5. Canada Host Cell Contaminant Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 4.5.1.6. Canada Host Cell Contaminant Testing Market by Platform, Value (US$ Bn), 2018 - 2031
      • 4.5.1.7. Canada Host Cell Contaminant Testing Market by Application, Value (US$ Bn), 2018 - 2031
      • 4.5.1.8. Canada Host Cell Contaminant Testing Market by End User, Value (US$ Bn), 2018 - 2031
    • 4.5.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Host Cell Contaminant Testing Market Outlook, 2018 - 2031

  • 5.1. Europe Host Cell Contaminant Testing Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. PCR-based Assays
      • 5.1.1.2. ELISA-based Assays
  • 5.2. Europe Host Cell Contaminant Testing Market Outlook, by Platform, Value (US$ Bn), 2018 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Microbial
      • 5.2.1.2. Mammalian
      • 5.2.1.3. Others
  • 5.3. Europe Host Cell Contaminant Testing Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Research & Development
      • 5.3.1.2. Clinical Applications
  • 5.4. Europe Host Cell Contaminant Testing Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 5.4.1. Key Highlights
      • 5.4.1.1. Biopharmaceutical Companies
      • 5.4.1.2. Contract Research Organizations
      • 5.4.1.3. Contract Manufacturing Organizations
      • 5.4.1.4. Academic & Research Institutes
  • 5.5. Europe Host Cell Contaminant Testing Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 5.5.1. Key Highlights
      • 5.5.1.1. Germany Host Cell Contaminant Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 5.5.1.2. Germany Host Cell Contaminant Testing Market by Platform, Value (US$ Bn), 2018 - 2031
      • 5.5.1.3. Germany Host Cell Contaminant Testing Market by Application, Value (US$ Bn), 2018 - 2031
      • 5.5.1.4. Germany Host Cell Contaminant Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 5.5.1.5. U.K. Host Cell Contaminant Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 5.5.1.6. U.K. Host Cell Contaminant Testing Market by Platform, Value (US$ Bn), 2018 - 2031
      • 5.5.1.7. U.K. Host Cell Contaminant Testing Market by Application, Value (US$ Bn), 2018 - 2031
      • 5.5.1.8. U.K. Host Cell Contaminant Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 5.5.1.9. France Host Cell Contaminant Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 5.5.1.10. France Host Cell Contaminant Testing Market by Platform, Value (US$ Bn), 2018 - 2031
      • 5.5.1.11. France Host Cell Contaminant Testing Market by Application, Value (US$ Bn), 2018 - 2031
      • 5.5.1.12. France Host Cell Contaminant Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 5.5.1.13. Italy Host Cell Contaminant Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 5.5.1.14. Italy Host Cell Contaminant Testing Market by Platform, Value (US$ Bn), 2018 - 2031
      • 5.5.1.15. Italy Host Cell Contaminant Testing Market by Application, Value (US$ Bn), 2018 - 2031
      • 5.5.1.16. Italy Host Cell Contaminant Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 5.5.1.17. Turkey Host Cell Contaminant Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 5.5.1.18. Turkey Host Cell Contaminant Testing Market by Platform, Value (US$ Bn), 2018 - 2031
      • 5.5.1.19. Turkey Host Cell Contaminant Testing Market by Application, Value (US$ Bn), 2018 - 2031
      • 5.5.1.20. Turkey Host Cell Contaminant Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 5.5.1.21. Russia Host Cell Contaminant Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 5.5.1.22. Russia Host Cell Contaminant Testing Market by Platform, Value (US$ Bn), 2018 - 2031
      • 5.5.1.23. Russia Host Cell Contaminant Testing Market by Application, Value (US$ Bn), 2018 - 2031
      • 5.5.1.24. Russia Host Cell Contaminant Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 5.5.1.25. Rest of Europe Host Cell Contaminant Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 5.5.1.26. Rest of Europe Host Cell Contaminant Testing Market by Platform, Value (US$ Bn), 2018 - 2031
      • 5.5.1.27. Rest of Europe Host Cell Contaminant Testing Market by Application, Value (US$ Bn), 2018 - 2031
      • 5.5.1.28. Rest of Europe Host Cell Contaminant Testing Market by End User, Value (US$ Bn), 2018 - 2031
    • 5.5.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Host Cell Contaminant Testing Market Outlook, 2018 - 2031

  • 6.1. Asia Pacific Host Cell Contaminant Testing Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. PCR-based Assays
      • 6.1.1.2. ELISA-based Assays
  • 6.2. Asia Pacific Host Cell Contaminant Testing Market Outlook, by Platform, Value (US$ Bn), 2018 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Microbial
      • 6.2.1.2. Mammalian
      • 6.2.1.3. Others
  • 6.3. Asia Pacific Host Cell Contaminant Testing Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. Research & Development
      • 6.3.1.2. Clinical Applications
  • 6.4. Asia Pacific Host Cell Contaminant Testing Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 6.4.1. Key Highlights
      • 6.4.1.1. Biopharmaceutical Companies
      • 6.4.1.2. Contract Research Organizations
      • 6.4.1.3. Contract Manufacturing Organizations
      • 6.4.1.4. Academic & Research Institutes
  • 6.5. Asia Pacific Host Cell Contaminant Testing Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 6.5.1. Key Highlights
      • 6.5.1.1. China Host Cell Contaminant Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 6.5.1.2. China Host Cell Contaminant Testing Market by Platform, Value (US$ Bn), 2018 - 2031
      • 6.5.1.3. China Host Cell Contaminant Testing Market by Application, Value (US$ Bn), 2018 - 2031
      • 6.5.1.4. China Host Cell Contaminant Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 6.5.1.5. Japan Host Cell Contaminant Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 6.5.1.6. Japan Host Cell Contaminant Testing Market by Platform, Value (US$ Bn), 2018 - 2031
      • 6.5.1.7. Japan Host Cell Contaminant Testing Market by Application, Value (US$ Bn), 2018 - 2031
      • 6.5.1.8. Japan Host Cell Contaminant Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 6.5.1.9. South Korea Host Cell Contaminant Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 6.5.1.10. South Korea Host Cell Contaminant Testing Market by Platform, Value (US$ Bn), 2018 - 2031
      • 6.5.1.11. South Korea Host Cell Contaminant Testing Market by Application, Value (US$ Bn), 2018 - 2031
      • 6.5.1.12. South Korea Host Cell Contaminant Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 6.5.1.13. India Host Cell Contaminant Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 6.5.1.14. India Host Cell Contaminant Testing Market by Platform, Value (US$ Bn), 2018 - 2031
      • 6.5.1.15. India Host Cell Contaminant Testing Market by Application, Value (US$ Bn), 2018 - 2031
      • 6.5.1.16. India Host Cell Contaminant Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 6.5.1.17. Southeast Asia Host Cell Contaminant Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 6.5.1.18. Southeast Asia Host Cell Contaminant Testing Market by Platform, Value (US$ Bn), 2018 - 2031
      • 6.5.1.19. Southeast Asia Host Cell Contaminant Testing Market by Application, Value (US$ Bn), 2018 - 2031
      • 6.5.1.20. Southeast Asia Host Cell Contaminant Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 6.5.1.21. Rest of Asia Pacific Host Cell Contaminant Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 6.5.1.22. Rest of Asia Pacific Host Cell Contaminant Testing Market by Platform, Value (US$ Bn), 2018 - 2031
      • 6.5.1.23. Rest of Asia Pacific Host Cell Contaminant Testing Market by Application, Value (US$ Bn), 2018 - 2031
      • 6.5.1.24. Rest of Asia Pacific Host Cell Contaminant Testing Market by End User, Value (US$ Bn), 2018 - 2031
    • 6.5.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Host Cell Contaminant Testing Market Outlook, 2018 - 2031

  • 7.1. Latin America Host Cell Contaminant Testing Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. PCR-based Assays
      • 7.1.1.2. ELISA-based Assays
  • 7.2. Latin America Host Cell Contaminant Testing Market Outlook, by Platform, Value (US$ Bn), 2018 - 2031
    • 7.2.1. Key Highlights
      • 7.2.1.1. Microbial
      • 7.2.1.2. Mammalian
      • 7.2.1.3. Others
  • 7.3. Latin America Host Cell Contaminant Testing Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Research & Development
      • 7.3.1.2. Clinical Applications
  • 7.4. Latin America Host Cell Contaminant Testing Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 7.4.1. Key Highlights
      • 7.4.1.1. Biopharmaceutical Companies
      • 7.4.1.2. Contract Research Organizations
      • 7.4.1.3. Contract Manufacturing Organizations
      • 7.4.1.4. Academic & Research Institutes
  • 7.5. Latin America Host Cell Contaminant Testing Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 7.5.1. Key Highlights
      • 7.5.1.1. Brazil Host Cell Contaminant Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 7.5.1.2. Brazil Host Cell Contaminant Testing Market by Platform, Value (US$ Bn), 2018 - 2031
      • 7.5.1.3. Brazil Host Cell Contaminant Testing Market by Application, Value (US$ Bn), 2018 - 2031
      • 7.5.1.4. Brazil Host Cell Contaminant Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 7.5.1.5. Mexico Host Cell Contaminant Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 7.5.1.6. Mexico Host Cell Contaminant Testing Market by Platform, Value (US$ Bn), 2018 - 2031
      • 7.5.1.7. Mexico Host Cell Contaminant Testing Market by Application, Value (US$ Bn), 2018 - 2031
      • 7.5.1.8. Mexico Host Cell Contaminant Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 7.5.1.9. Argentina Host Cell Contaminant Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 7.5.1.10. Argentina Host Cell Contaminant Testing Market by Platform, Value (US$ Bn), 2018 - 2031
      • 7.5.1.11. Argentina Host Cell Contaminant Testing Market by Application, Value (US$ Bn), 2018 - 2031
      • 7.5.1.12. Argentina Host Cell Contaminant Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 7.5.1.13. Rest of Latin America Host Cell Contaminant Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 7.5.1.14. Rest of Latin America Host Cell Contaminant Testing Market by Platform, Value (US$ Bn), 2018 - 2031
      • 7.5.1.15. Rest of Latin America Host Cell Contaminant Testing Market by Application, Value (US$ Bn), 2018 - 2031
      • 7.5.1.16. Rest of Latin America Host Cell Contaminant Testing Market by End User, Value (US$ Bn), 2018 - 2031
    • 7.5.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Host Cell Contaminant Testing Market Outlook, 2018 - 2031

  • 8.1. Middle East & Africa Host Cell Contaminant Testing Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. PCR-based Assays
      • 8.1.1.2. ELISA-based Assays
  • 8.2. Middle East & Africa Host Cell Contaminant Testing Market Outlook, by Platform, Value (US$ Bn), 2018 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. Microbial
      • 8.2.1.2. Mammalian
      • 8.2.1.3. Others
  • 8.3. Middle East & Africa Host Cell Contaminant Testing Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. Research & Development
      • 8.3.1.2. Clinical Applications
  • 8.4. Middle East & Africa Host Cell Contaminant Testing Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 8.4.1. Key Highlights
      • 8.4.1.1. Biopharmaceutical Companies
      • 8.4.1.2. Contract Research Organizations
      • 8.4.1.3. Contract Manufacturing Organizations
      • 8.4.1.4. Academic & Research Institutes
  • 8.5. Middle East & Africa Host Cell Contaminant Testing Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 8.5.1. Key Highlights
      • 8.5.1.1. GCC Host Cell Contaminant Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 8.5.1.2. GCC Host Cell Contaminant Testing Market by Platform, Value (US$ Bn), 2018 - 2031
      • 8.5.1.3. GCC Host Cell Contaminant Testing Market by Application, Value (US$ Bn), 2018 - 2031
      • 8.5.1.4. GCC Host Cell Contaminant Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 8.5.1.5. South Africa Host Cell Contaminant Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 8.5.1.6. South Africa Host Cell Contaminant Testing Market by Platform, Value (US$ Bn), 2018 - 2031
      • 8.5.1.7. South Africa Host Cell Contaminant Testing Market by Application, Value (US$ Bn), 2018 - 2031
      • 8.5.1.8. South Africa Host Cell Contaminant Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 8.5.1.9. Egypt Host Cell Contaminant Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 8.5.1.10. Egypt Host Cell Contaminant Testing Market by Platform, Value (US$ Bn), 2018 - 2031
      • 8.5.1.11. Egypt Host Cell Contaminant Testing Market by Application, Value (US$ Bn), 2018 - 2031
      • 8.5.1.12. Egypt Host Cell Contaminant Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 8.5.1.13. Nigeria Host Cell Contaminant Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 8.5.1.14. Nigeria Host Cell Contaminant Testing Market by Platform, Value (US$ Bn), 2018 - 2031
      • 8.5.1.15. Nigeria Host Cell Contaminant Testing Market by Application, Value (US$ Bn), 2018 - 2031
      • 8.5.1.16. Nigeria Host Cell Contaminant Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 8.5.1.17. Rest of Middle East & Africa Host Cell Contaminant Testing Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 8.5.1.18. Rest of Middle East & Africa Host Cell Contaminant Testing Market by Platform, Value (US$ Bn), 2018 - 2031
      • 8.5.1.19. Rest of Middle East & Africa Host Cell Contaminant Testing Market by Application, Value (US$ Bn), 2018 - 2031
      • 8.5.1.20. Rest of Middle East & Africa Host Cell Contaminant Testing Market by End User, Value (US$ Bn), 2018 - 2031
    • 8.5.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Product Type vs Platform Heatmap
  • 9.2. Manufacturer vs Platform Heatmap
  • 9.3. Company Market Share Analysis, 2023
  • 9.4. Competitive Dashboard
  • 9.5. Company Profiles
    • 9.5.1. BioGenes GmbH
      • 9.5.1.1. Company Overview
      • 9.5.1.2. Product Type Portfolio
      • 9.5.1.3. Financial Overview
      • 9.5.1.4. Business Strategies and Development
    • 9.5.2. Bio-Rad Laboratories, Inc.
      • 9.5.2.1. Company Overview
      • 9.5.2.2. Product Type Portfolio
      • 9.5.2.3. Financial Overview
      • 9.5.2.4. Business Strategies and Development
    • 9.5.3. Cisbio Bioassays
      • 9.5.3.1. Company Overview
      • 9.5.3.2. Product Type Portfolio
      • 9.5.3.3. Financial Overview
      • 9.5.3.4. Business Strategies and Development
    • 9.5.4. Cygnus Technologies LLC
      • 9.5.4.1. Company Overview
      • 9.5.4.2. Product Type Portfolio
      • 9.5.4.3. Financial Overview
      • 9.5.4.4. Business Strategies and Development
    • 9.5.5. Enzo Life Sciences, Inc.
      • 9.5.5.1. Company Overview
      • 9.5.5.2. Product Type Portfolio
      • 9.5.5.3. Financial Overview
      • 9.5.5.4. Business Strategies and Development
    • 9.5.6. ForteBio
      • 9.5.6.1. Company Overview
      • 9.5.6.2. Product Type Portfolio
      • 9.5.6.3. Financial Overview
      • 9.5.6.4. Business Strategies and Development
    • 9.5.7. GE Healthcare Life Sciences
      • 9.5.7.1. Company Overview
      • 9.5.7.2. Product Type Portfolio
      • 9.5.7.3. Financial Overview
      • 9.5.7.4. Business Strategies and Development
    • 9.5.8. Molecular Devices LLC
      • 9.5.8.1. Company Overview
      • 9.5.8.2. Product Type Portfolio
      • 9.5.8.3. Financial Overview
      • 9.5.8.4. Business Strategies and Development
    • 9.5.9. ProteinSimple
      • 9.5.9.1. Company Overview
      • 9.5.9.2. Product Type Portfolio
      • 9.5.9.3. Financial Overview
      • 9.5.9.4. Business Strategies and Development
    • 9.5.10. Thermo Fisher Scientific, Inc.
      • 9.5.10.1. Company Overview
      • 9.5.10.2. Product Type Portfolio
      • 9.5.10.3. Financial Overview
      • 9.5.10.4. Business Strategies and Development

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations